Skip to content

ANSELMO PHARMA

Active Risk: not assessed Private limited companyfounded 2023active for 3 yearsDraakplaats 4, 2018 AntwerpKBO/BCE: BE 0798.184.888

Timeline

9 events since 2023

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBabbreviated format · 10 days late
2025
Highest result from 2023 to 2025 net €62,258 ▲3.6% The operating result of €110,285 and the net result of €62,258 are both a record.
Equity above €150,000 equity €183,073 ▲50.5% With a profit in every financial year since 2023, equity grows to €183,073.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0798184888
Annual accounts 2024 filed PDFabbreviated format · 3 days before the deadline
2024
Equity above €100,000 equity €121,647 ▲97.7% With a profit in every financial year since 2023, equity grows to €121,647.
Annual accounts 2023 filed PDFabbreviated format · 26 days late
2023
First establishment Draakplaats 4, Antwerp
IncorporationFounding capital of €25,000, 100 shares · Founded by · appointed as director · published on 09-02-20233 points ▸
  • Founded by
  • The founding capital is €25,000, divided into 100 shares
  • appointed as director
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

ANSELMO PHARMA was incorporated on 7 February 2023 as a private limited company by one private individual, with a starting capital of €25,000.12 is director of the company, appointed by deed of 09-02-2023.2 Total assets went from €899,138 in 2023 to €960,281 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 09-02-2023
  3. 3National Bank, annual accounts 2023 and 2025

Next steps